Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 19, 2015 - Issue 2
Submit an article Journal homepage
366
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

“Long-acting” olanzapine in maintenance therapy of schizophrenia: A study with plasma levels

Massimo C. MauriClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyCorrespondence[email protected]
,
Michele MaffiniClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Chiara Di PaceClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Alessandra ReggioriClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Silvia PalettaClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Donatella MoliternoClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Chiara RoveraClinical Neuropsychopharmacology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
&
Carlo A. AltamuraDepartment of Neuroscience and Mental Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
 show all
Pages 99-105 | Received 31 Jan 2014, Accepted 16 Dec 2014, Published online: 30 Dec 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano, Luca Steardo, Clemente Cedro, Antonio Bruno, Rocco Antonio Zoccali & Maria Rosaria Anna Muscatello. (2021) Current and emerging long-acting antipsychotics for the treatment of schizophrenia. Expert Opinion on Drug Safety 20:7, pages 771-790.
Read now
Ludovic Samalin, Ricardo Garay, Ahcène Ameg & Pierre-Michel Llorca. (2016) Olanzapine pamoate for the treatment of schizophrenia – a safety evaluation. Expert Opinion on Drug Safety 15:3, pages 403-411.
Read now

Articles from other publishers (11)

Eun-Jeong Joo, Kyu Young Lee, Seong Hoon Jeong & Yong Sik Kim. (2023) Breakthrough Psychosis and Long-Acting Injectable Antipsychotics. Korean Journal of Schizophrenia Research 26:1, pages 1-11.
Crossref
Stefanie Fekete, Tim Güntzel, Karin Egberts, Julia Geissler, Antje Neubert, Manfred Gerlach, Marcel Romanos & Regina Taurines. (2022) Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring. Pharmacopsychiatry 56:01, pages 32-39.
Crossref
Giulio D'Anna, Francesco Rotella, Gabriele Santarelli, Silvia Scannerini, Alessandra Fanelli, Valdo Ricca & Andrea Ballerini. (2022) Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotics as a Predictor of Relapse in Schizophrenia Spectrum Disorders: A 1-Year Pilot Study. Therapeutic Drug Monitoring 44:6, pages 805-810.
Crossref
Enrico Capuzzi, Alessandro Ceresa, Alice Caldiroli, Cecilia M. Esposito, Paolo Ossola & Massimiliano Buoli. (2021) The Relation between the Plasma Concentrations of Long-Acting Atypical Antipsychotics and Clinical Effectiveness in Patients Affected by Schizophrenia or Schizoaffective Disorder: A Comprehensive Overview. Current Pharmaceutical Design 27:39, pages 4070-4077.
Crossref
Georgios SchoretsanitisPierre BaumannAndreas ConcaOtto DietmaierGiancarlo GiupponiGerhard GründerMartina HahnXenia HartUrsula Havemann-ReineckeGudrun HefnerMaxim KuzinRainald MössnerDaria PiacentinoWerner SteimerGerald Zernig & Christoph Hiemke. (2021) Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs. Therapeutic Drug Monitoring 43:1, pages 79-102.
Crossref
Christopher Noel. (2019) A review of a recently published guidelines' “strong recommendation” for therapeutic drug monitoring of olanzapine, haloperidol, perphenazine, and fluphenazine. Mental Health Clinician 9:4, pages 287-293.
Crossref
N. V. Baymeeva, A. I. Platova, V. G. Kaleda & I. I. Miroshnichenko. (2019) Therapeutic drug monitoring of risperidone and its active metabolite 9-hydroxyrisperidone in the treatment of schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:3, pages 24.
Crossref
M. C. Mauri & C. Di Pace. 2019. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches 245 257 .
Marit Tveito, Robert L. Smith, Espen Molden, Tore Haslemo, Helge Refsum, Cecilie Hartberg, Christoph U. Correll & Gudrun Høiseth. (2018) Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations. Journal of Clinical Psychopharmacology 38:6, pages 570-576.
Crossref
Massimo Carlo Mauri, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Giovanna Cirnigliaro, Isabel Valli & Alfredo Carlo Altamura. (2018) Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. Clinical Pharmacokinetics 57:12, pages 1493-1528.
Crossref
A. Carlo Altamura, Giuseppe Delvecchio, Silvia Paletta, Chiara Di Pace, Alessandra Reggiori, Alessio Fiorentini, M. Donatella Mirabile, Riccardo A. Paoli, Claudia Cinnante, Fabio Triulzi, Massimo C. Mauri & Paolo Brambilla. (2017) Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study. Psychiatry Research: Neuroimaging 261, pages 80-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.